rbl100
3 minutes ago
FDA APPROVES FBIO cancer drug !!!!
FDA approves cosibelimab-ipdl for metastatic or locally advanced cutaneous squamous cell carcinoma
On December 13, 2024, the Food and Drug Administration approved cosibelimab-ipdl (Unloxcyt, Checkpoint Therapeutics, Inc.), a programme